Arranz M.J., Lin M-W., Powell J., Kerwin R., Collier D. (1996) 5-HT2A receptor T102C polymorphism and schizophrenia. Lancet347: 1831
2.
Burnet P W J, Harrison P.J. (1995) Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet346: 909
3.
Burnet P W J, Eastwood S.L., Lacey K.L., Harrison P.J. (1995) The distribution of 5-HT1A and 5-HT 2A receptor mRNAs in human brain. Brain Res676: 157-168
4.
Burnet P W J, Chen C P L-H, McGowan S., Franklin M., Harrison P.J. (1996a) The effects of clozapine and haloperidol on serotonin-1A, -2A, and -2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience73: 531-540
5.
Burnet P W J, Eastwood S.L., Harrison P.J. (1996b) 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially affected in schizophrenia . Neuropsychopharmacology15: 422-435
6.
Clifford C.P., Nunez D J R (1996) 5-HT2A receptor T102C polymorphism and schizophrenia. Lancet347: 1830
7.
Crow T.J. (1996) 5-HT2A receptor T102C polymorphism and schizophrenia. Lancet347:1832
8.
Crowe R.R. (1993) Candidate genes in psychiatry: an epidemiological perspective. Am J Med Genet (Neuropsychiat Genet) 48: 74-77
9.
Harrison P.J., Geddes J.R. (1996) Schizophrenia and the 5-HT2A receptor gene [Commentary]. Lancet347: 1274
10.
Inayama Y., Yoneda H., Sakai T., Ishida T., Nonomura Y., Kono Y., Takahata R., Koh J., Sakai J., Takai A., Inada Y., Asaba H. (1996) Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am J Med Genet67: 103-105
11.
Ishigaki T., Xie D-W., Liu J-C., Nakamura Y., Zhang H-Y., Tani K., Shimazu Y., Chen K., Shih J.C., Miyatso K., Ohara K., Ohara K. (1996) Intact 5-HT2A receptor exons and adjoining intron regions in schizophrenia. Neuropsychopharmacology14: 339-347Jonsson E., Nothen M.M., Bunzel R., Propping P., Sedvall G. (1996) 5-HT2a receptor T102C polymorphism and schizophrenia. Lancet347: 1831
12.
Kerwin R.W., Dumon V. (1994) Dopamine receptor genes and schizophrenia: the tail wags the dog? Lancet343: 686
13.
Kidd K.K. (1993) Associations of disease with genetic markers: déjà vu all over again. Am J Med Genet (Neuropsychiat Genet) 48: 71-73
14.
Kuoppamäki M., Palvimäki E-P., Hietala J., Syvalähti E. (1995) Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs. Neuropsychopharmacology13:139-150
15.
Malhotra A.K., Goldman D., Buchanan R., Breier A., Pickar D. (1996) 5-HT2a receptor T102C polymorphism and schizophrenia. Lancet347:1830-1831
16.
Masellis M., Paterson A.D., Badri F., Lieberman J.A., Meltzer H.Y., Cavazzoni P., Kennedy J.L. (1996) Genetic variation of 5-HT2A receptor and response to clozapine. Lancet346: 908-909
17.
Mui S., Briggs M., Chung H., Wallace R.B., Gomez-IslaT., Rebeck G.W., Hyman B.T. (1996) A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the ε4 allele. Neurology47: 196-201
18.
Nöthen M.M., Rietschel M., Erdmann J., Oberlander H., Moller H.J., Naber D., Propping P. (1996) Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet346: 1108
19.
Owen M.J., McGuflin P. (1993) Association and linkage: complementary strategies for complex disorders. J Med Genet30: 638-639
20.
Sasaki T., Hattori M., Fukuda R., Kunugi H., Nanko S. (1996) 5-HT2A receptor T102C polymorphism and schizophrenia. Lancet347: 1832
21.
Strittmatter W.J., Roses A.D. (1996) Apolipoprotein E and Alzheimer's disease. Ann Rev Neurosci19: 53-77
22.
Williams J., Spurlock G., McGuffin P., Mallet J., Nothen M.M., Gill M., Aschauer H., Nylander P.O., Macciarfi F., Owen M.J. (1996) Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. Lancet347: 1294-1296
